FIM
GBT
Fernwood Investment Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-174,724
| Closed | -$11.9M | – | 191 |
|
|
2022
Q3 | $11.9M | Sell |
174,724
-28,026
| -14% | -$1.91M | 5.02% | 2 |
|
|
2022
Q2 | $6.48M | Sell |
202,750
-7,225
| -3% | -$231K | 2.79% | 4 |
|
|
2022
Q1 | $7.27M | Sell |
209,975
-375
| -0.2% | -$13K | 2.55% | 6 |
|
|
2021
Q4 | $6.16M | Sell |
210,350
-2,775
| -1% | -$81.2K | 2.01% | 8 |
|
|
2021
Q3 | $5.43M | Buy |
213,125
+5,000
| +2% | +$127K | 1.87% | 11 |
|
|
2021
Q2 | $7.29M | Buy |
208,125
+1,518
| +0.7% | +$53.2K | 2.41% | 9 |
|
|
2021
Q1 | $8.42M | Buy |
206,607
+4,950
| +2% | +$202K | 3.1% | 3 |
|
|
2020
Q4 | $8.73M | Buy |
201,657
+14,180
| +8% | +$614K | 3.44% | 2 |
|
|
2020
Q3 | $10.3M | Sell |
187,477
-8,900
| -5% | -$491K | 4.88% | 1 |
|
|
2020
Q2 | $12.4M | Sell |
196,377
-8,535
| -4% | -$539K | 6.13% | 1 |
|
|
2020
Q1 | $10.5M | Sell |
204,912
-53,100
| -21% | -$2.71M | 6.68% | 1 |
|
|
2019
Q4 | $20.5M | Sell |
258,012
-70,550
| -21% | -$5.61M | 9.81% | 1 |
|
|
2019
Q3 | $15.9M | Buy |
328,562
+657
| +0.2% | +$31.9K | 7.9% | 1 |
|
|
2019
Q2 | $17.2M | Buy |
327,905
+3,028
| +0.9% | +$159K | 9.44% | 1 |
|
|
2019
Q1 | $17.2M | Sell |
324,877
-32,335
| -9% | -$1.71M | 9.17% | 1 |
|
|
2018
Q4 | $14.7M | Sell |
357,212
-26,490
| -7% | -$1.09M | 9.45% | 1 |
|
|
2018
Q3 | $14.6M | Buy |
383,702
+27,633
| +8% | +$1.05M | 7.71% | 1 |
|
|
2018
Q2 | $16.1M | Buy |
356,069
+560
| +0.2% | +$25.3K | 8.69% | 1 |
|
|
2018
Q1 | $17.2M | Sell |
355,509
-3,585
| -1% | -$173K | 9.58% | 1 |
|
|
2017
Q4 | $14.1M | Sell |
359,094
-58,916
| -14% | -$2.32M | 7.56% | 1 |
|
|
2017
Q3 | $13M | Buy |
418,010
+136,553
| +49% | +$4.24M | 8.13% | 1 |
|
|
2017
Q2 | $7.7M | Buy |
281,457
+18,947
| +7% | +$518K | 5.58% | 2 |
|
|
2017
Q1 | $9.67M | Buy |
262,510
+205,026
| +357% | +$7.55M | 7.7% | 1 |
|
|
2016
Q4 | $831K | Buy |
57,484
+17,484
| +44% | +$253K | 0.8% | 42 |
|
|
2016
Q3 | $922K | Buy |
40,000
+100
| +0.3% | +$2.31K | 0.84% | 42 |
|
|
2016
Q2 | $662K | Buy |
39,900
+19,950
| +100% | +$331K | 0.65% | 49 |
|
|
2016
Q1 | $316K | Buy |
+19,950
| New | +$316K | 0.32% | 79 |
|